<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>NCState: Judging Session</title>
        <link>https://video.igem.org/videos/watch/a471457e-aeb0-49e7-a09e-31768a8d85ba</link>
        <description>To address growing antimicrobial resistance this study evaluated the feasibility of engineering S. boulardii to produce four functional antimicrobial peptides (AMPs): LL37, AMP-17, ToAP2, and P113, and assess their anti bacterial effects. Digitally designed plasmids, later constructed in lab via Golden Gate assembly were transformed into S. boulardii strains to evaluate AMP production, growth rates, and cellular morphology.  Unmodified S. boulardii (PY0001) showed no native hemolytic or antimicrobial activity. Modified strains (LL37, AMP17) had significantly reduced growth rates (p=6.4278×10^−6) compared to PY0001, likely caused by nourseothricin (NAT) in the selective media. NAT substantially reduced B. subtilis and E. coli viability, whereas P. putida was moderately sensitive. Notably, AMP17 significantly inhibited P. putida growth (p=0.003553) in our agar diffusion assay. Although NAT reduced growth rates, AMP17 successfully inhibited P. putida, demonstrating the feasibility of engineering S. boulardii as a therapeutic probiotic against resistant bacteria.</description>
        <lastBuildDate>Sat, 21 Nov 2026 11:26:39 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>PeerTube - https://video.igem.org</generator>
        <image>
            <title>NCState: Judging Session</title>
            <url>https://video.igem.org/client/assets/images/icons/icon-1500x1500.png</url>
            <link>https://video.igem.org/videos/watch/a471457e-aeb0-49e7-a09e-31768a8d85ba</link>
        </image>
        <copyright>All rights reserved, unless otherwise specified in the terms specified at https://video.igem.org/about and potential licenses granted by each content's rightholder.</copyright>
        <atom:link href="https://video.igem.org/feeds/video-comments.xml?videoId=a471457e-aeb0-49e7-a09e-31768a8d85ba" rel="self" type="application/rss+xml"/>
    </channel>
</rss>